Contemporary outcomes of mechanical circulatory support using paracorporeal continuous flow pump in children: A

Jiyong Moon1, Lawrence Greiten2, Christina Vander3

  • 1Division of Cardiovascular and Thoracic Surgery, Dell Children's Medical Center, Austin, Texas.

Insights

Mechanical circulatory support with paracorporeal continuous flow (pCF) pumps in children achieved a 78% positive outcome. Congenital heart disease patients experienced worse outcomes and higher mortality compared to non-CHD patients.

Area of Science:

  • Pediatric Cardiology
  • Mechanical Circulatory Support
  • Congenital Heart Disease

Background:

  • Mechanical circulatory support (MCS) is crucial for pediatric end-stage heart failure.
  • Paracorporeal continuous flow (pCF) pumps are increasingly used in pediatric MCS.
  • Evaluating the clinical outcomes of pCF pumps in children is essential.

Purpose of the Study:

  • To assess the efficacy and safety of pCF pumps in pediatric patients.
  • To compare outcomes between children with and without congenital heart disease (CHD).
  • To analyze outcomes based on CHD physiology (single vs. biventricular).

Main Methods:

  • Multicenter retrospective study using the ACTION database (April 2018 - July 2023).
  • Included children supported with pCF pumps.
  • Primary outcome: survival to transplant, explant, or durable device; secondary outcomes: adverse events.

Main Results:

  • 367 patients (204 CHD, 163 non-CHD) received pCF support (median 25 days).
  • Overall positive outcome was 77.9% (survival/durable device/recovery).
  • CHD patients had lower positive outcomes (73.0% vs. 82.2%) and higher mortality (24% vs. 14.1%) compared to non-CHD.

Conclusions:

  • pCF pump use in children is associated with a 78% positive outcome in a contemporary cohort.
  • Children with CHD demonstrate poorer outcomes and increased mortality with pCF support.
  • Outcomes were comparable between single and biventricular CHD, but single ventricles had lower recovery rates.
Abstract